43 results
Page 2 of 3
424B2
7npzdv79c5 0x
13 Jun 14
Prospectus for primary offering
12:00am
F-3
7t248ucb jv
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
w9rd7eeccyx1o7v l3
30 May 14
Current report (foreign)
12:00am
6-K
EX-1.1
uc7uoizccrwi13w4j
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B3
40dus
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
aos45qq zd
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
5l9uhqgmpsb8dz
15 Oct 12
Prospectus supplement
12:00am
F-1
kvi a3z2mrqucandp3r
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
t4du3x1 05sdlpl9xx
27 Sep 12
Current report (foreign)
12:00am
S-8
EX-3.1
p3zq ml3h
19 Sep 12
Registration of securities for employees
12:00am
424B3
u50hvgqc
2 Aug 12
Prospectus supplement
12:00am
POS AM
le7yd opg5zi
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
a1imysq
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
8v0r9tfus5x634e
28 Mar 12
Prospectus supplement
12:00am
6-K
EX-1
40vo6klm dx
13 Oct 11
Current report (foreign)
12:00am
20FR12B
EX-4.17
u2acki3fchtmgxnrg9pu
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.24
b0cqi7kifefjxe zn
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.19
golxjvt8
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.4
sivhrz nl3k14
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am